Tag:

oncology

Latest Headlines

Latest Headlines

GlaxoSmithKline initiates global cancer consortium

GlaxoSmithKline is launching what it calls the Oncology Clinical and Translational Consortium, a collaborative scientific research network intended to advance drug discovery that will include 6 cancer centers around the world.

Indian agency objects to Mylan vaccine plant deal

Indian officials fear the sale of the vaccine and oncology plants will limit the country's ability to supply affordable medicines to citizens.

Ex-Googlers bring Big Data analytics to oncology

When ex-Google ($GOOG) guys Nat Turner and Zach Weinberg discussed their oncology-focused startup Flatiron Health in August they were big on ambition but low on details.

Biomarker shines a light on new pathway to target neuroblastoma

A group of investigators at the prestigious Dana-Farber/Children's Hospital Cancer Center in Boston believe they may have identified the Achilles heel for a common malignant tumor found in pediatric oncology.

Bringing personalized medicine to the market

Personalized medicine has been the holy grail of diagnostics and biomarkers for some time, but at last, it seems like it is becoming a reality. Jan Groen, CEO at MDxHealth, spoke to FierceBiomarkers at BIO2012 about this growing field.

Algorithms espy tumor conspirators

Cancer systems biology algorithms have led researchers to two genes that collaborate to cause an aggressive brain tumor. Researchers from Columbia University and oncology drug discovery company

Promising cancer drug could be studied in humans

A potential treatment for small cell lung cancer may head to clinical trials next year following the publication of promising results of a mice study in the journal Cancer Research. Researchers from

Software updated for cancer collaborators

The OnCore clinical research management system "sports a sleek new user interface" and incorporates hundreds of enhancement requests provided by 20 research organizations, according to developer

Glaxo decides bigger is better for cancer research

Late last week GlaxoSmithKline announced a newly re-engineered program for cancer R&D. The pharma giant had

Celldex inks tech deal to advance cancer vaccines

Celldex Therapeutics has struck a deal to use 3M's toll-like receptor (TLR) agonist compounds--useful as vaccine adjuvants--for a slate of new oncology vaccines in development. 3M Drug Delivery